TGA Approval

PIQRAY alpelisib 250 mg daily dose blister (200+50 mg tablet) composite pack (315055)

ARTG ID

315055

ARTG Name

PIQRAY alpelisib 250 mg daily dose blister (200+50 mg tablet) composite pack

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

March 20, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/eed3c978a3eb97bc88a273c287882d72.pdf

https://medical-cdn.nocode.com/drug_tga/f3fd71fa20944ddd5abbf10be22f3f3c.pdf

Ingredient Name

alpelisib

Empowering clinical research with data-driven insights and AI-powered tools.

PIQRAY alpelisib 250 mg daily dose blister (200+50 mg tablet) composite pack (315055) - TGA 批准文号 | MedPath